We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Two Industry Partnerships Initiated to Fuel Neuroscience Research

By LabMedica International staff writers
Posted on 16 Nov 2014
Faster, more complex neural research is now attainable by combining technology from two research companies.

Blackrock Microsystems, LLC (Salt Lake City, UT, USA), a developer of neuroscience research equipment, announced partnerships with two neuroscience research firms—PhenoSys, GmbH (Berlin, Germany) and NAN Instruments, Ltd. More...
(Nazareth, Israel) that will create a truly comprehensive set of tools for neuroscience researchers that should facilitate faster and more cost-effective research. Blackrock Microsystems will integrate specific technologies from PhenoSys and NAN Instruments to offer a fully cohesive range of electrophysiology research products.

“Our partnerships with PhenoSys and NAN instruments will fundamentally change the way neuroscientists work, so that regardless of the experiment the researcher dreams up, we can now empower them to perform it,” said Andy Gotshalk, CEO of Blackrock Microsystems. “Neuroscience research is often encumbered by mix-and-match components and complicated experiment setups. These partnerships will lessen time-consuming, expensive barriers and expedite research results so that we can achieve our ultimate objective of transferring those results into clinical practice for the millions of people facing devastating neurophysiologic challenges.”

Blackrock Microsystems’ miniaturized electrodes and amplifiers, and its data acquisition platform help researchers to perform experiments on nearly unencumbered subjects, thus yielding a clearer look into the brain's natural architecture.

PhenoSys’ technology allows researchers to construct virtual-reality mazes, where scientists can implement improvised alterations to experiments, leading to considerable cost savings of both time and money. Prior to this technology, researchers spent hours constructing physical mazes and other research environments.

“Our virtual-reality technology is already transforming neuroscience research,” said York Winter, PhD, CEO and co-founder of PhenoSys, and professor of cognitive neurobiology at Humboldt University (Berlin, Germany). “By teaming up with Blackrock Microsystems, we'll be able to help even more scientists conduct experiments that were previously thought impossible.”

NAN Instruments designs and manufactures the only electrode positioning system capable of moving individual electrodes fractions of a millimeter in a three-dimensional (3D) space. With this technology, neuroscientists can differentiate between neuron groups that were previously inseparable.

“NAN Instruments prides itself on providing flexible and reliable electrode drives,” said Nabeel Abunassar, CEO of NAN Instruments, Ltd. “Our collaboration with Blackrock Microsystems, leverages our combined strengths as leaders in the field of neuroscience research to provide integrated systems for our customers on a global scale.”

Blackrock Microsystems has become a world-leading provider of technology in the neuroscience, neural engineering, and neural prosthetics space. The company’s technology has been at the center of worldwide developments in brain machine interface), implantable bionic technologies and epilepsy diagnostics.

PhenoSys is a research and development company that engineers and markets advanced technology for automated animal behavior research. The PhenoSys investigators holds extensive expertise in electrical and mechanical engineering, computer science, and behavioral biology to create experimental systems used for behavioral phenotyping, brain research, experimental psychology, and diagnostic characterization of animal models for translational medicine.

NAN Instruments designs and manufactures devices for recording electrical activity from the brain and nervous system. The unique design of the company’s electrode positioning systems provides users with effective tools that allow manipulation of each electrode individually in 3D spaces.

Related Links:

Blackrock Microsystems 
PhenoSys 
NAN Instruments



New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Pan-Cancer Panel
TruSight Oncology 500
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.